SCHEMBL2168154

SCHEMBL2168154

CC(=O)OCC(C)OS(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 5/20 0.36
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM1 P11229 2/20 0.36
TBXA2R P21731 2/20 0.36
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 2/20 0.35
GALR3 O60755 1/20 0.35
BLM P54132 1/20 0.35
ALOX15 P16050 1/20 0.31
PGR P06401 1/20 0.30
HTR1A P08908 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRM3 P20309 1/20 0.30
CHRNB4 P30926 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124717 0.82 ALDH1A1 (0.39) ALDH1A1TSHRCHRM2CHRM4CHRM1
SCHEMBL3702838 0.81 TSHR (0.63) ALDH1A1TSHR
SCHEMBL2166698 0.80 ALOX15 (0.43) ALDH1A1TSHRCHRM2CHRM4CHRM1
Propylene Glycol Diacetate SCHEMBL49091 0.78 TDP1 (0.54) ALDH1A1TDP1TSHRCHRM2CHRM4
Propylene Glycol Diacetate SCHEMBL8503200 0.78 TDP1 (0.54) ALDH1A1TDP1TSHRCHRM2CHRM4
SCHEMBL21905419 0.77 TSHR (0.63) ALDH1A1TSHRHSD17B10SMN1; SMN2CYP3A4
SCHEMBL2166966 0.77 ALDH1A1 (0.44) ALDH1A1TSHRCHRM2CHRM4CHRM1
SCHEMBL19525675 0.76 ALDH1A1 (0.34) ALDH1A1TDP1TSHRLMNAHSD17B10
Acetic Acid Isobutyl Ester SCHEMBL27782592 0.76 TSHR (0.50) ALDH1A1TDP1TSHRCHRM2CHRM4
Acetic Acid Isobutyl Ester SCHEMBL22678 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383274-B2 Nonaqueous electrolyte solution for lithium battery, lithium battery using same, and formyloxy group-containing compound used therein UBE INDUSTRIES, LTD. (JP) 2013-02-26 US disclosed
US-20110183199-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN UBE INDUSTRIES, LTD. (JP) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183199-A1 NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN HCN2, KCNN2, KCNB1 ALDH1A1 2190/4885TDP1 2834/4885TSHR 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.